Exercise echocardiography reflects cumulative anthracycline exposure during childhood
Authors:
- Elizabeth SmibertESElizabeth Smibert
- John B. CarlinJCJohn B. Carlin
- Suzanna VidmarSVSuzanna Vidmar
- Robert G. WeintraubRWRobert G. Weintraub
- 1 March 2004
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 42 (7) , 556-562
Abstract
Background: Low and moderate dose anthracycline therapy used in current treatment protocols, may be associated with subclinical abnormalities of cardiac function and late presentation with congestive heart failure. Exercise echocardiography is a useful and non‐invasive means of uncovering latent cardiac dysfunction in other settings. The purpose of this study is to determine whether exercise echocardiography has the potential to detect subclinical abnormalities of cardiac function in children treated with anthracyclines.Procedure: One hundred ten children previously treated with anthracycline, in remission and off treatment for >12 months were assessed, together with 31 control subjects. Each subject had a resting ECG and echocardiogram performed, and following exercise on a treadmill according to the Bruce protocol, a repeat echocardiogram was performed.Results: Cumulative anthracycline dose was the only patient variable related to any of the outcome measures. Resting fractional shortening was normal in the majority of treated patients but was inversely related to cumulative anthracycline dose (rate of decline 1.2%/100 mg/m2). Following peak exercise, the inverse relationship between fractional shortening and anthracycline dose was more pronounced (rate 2.7%/100 mg/m2).Conclusions: Higher anthracycline doses are associated with a greater difference in peak fractional shortening between treated subjects and controls. Exercise echocardiography is a simple, relatively inexpensive tool that may enhance the detection of latent cardiac dysfunction after anthracycline administration during childhood.Keywords
Funding Information
- Royal Children's Hospital Research Institute, Victoria, Australia (95-35)
This publication has 39 references indexed in Scilit:
- Cardiac Failure and Dysrhythmias 6–19 Years After Anthracycline Therapy: A Series of 15 PatientsMedical and Pediatric Oncology, 1995
- Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: Diastolic versus systolic parametersEuropean Journal of Pediatrics, 1995
- Re: “Letter to the editor: Increased risk of cardiac dysfunction after anthracyclines in girls”Medical and Pediatric Oncology, 1995
- Electrocardiographic changes and arrhythmias after cancer therapy in children and young adultsThe American Journal of Cardiology, 1992
- Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancerJACC, 1992
- Functional myocardial impairment in children treated with anthracyclines for cancerThe Lancet, 1991
- Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.Heart, 1988
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Response of the left ventricle to stress: Effects of exercise, atrial pacing, afterload stress and drugsThe American Journal of Cardiology, 1981
- Echocardiographic measurements in normal subjects from infancy to old age.Circulation, 1980